The Impact of the American Health Care Act on Rare Disease Patients
The American Health Care Act, the bill intended to replace the Patient Protection and Affordable Care Act (ACA), is swiftly making its...
What Does The Scrutiny on Orphan Drug Pricing Mean For Manufacturers and Consumers?
Ongoing changes in U.S. healthcare reform and the Congressional inquiry into the Orphan Drug Act’s effect on drug pricing have created a...
Rare Disease Day
Diligentia honors the 10th anniversary of International Rare Disease Day taking place on February 28, 2017. Originally established by...
International Conference on Rare Diseases and Orphan Drugs Announces New Board of Directors
Diverse body of expertise to tackle the challenges of rare diseases (Stockholm, Sweden) – November 14, 2016. The International Conference...
Meet with us at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco January 9-12, 201
If you are attending the conference and would like to learn about how Diligentia can support your commercial business objectives, email...
